The University of Washington Division of Rheumatology is committed to supporting biomedical research endeavors to improve rheumatic and autoimmune disease outcomes. Led by Dr. Bobby Han, we partner with practicing physicians and industry sponsors to conduct health-related interventional and observational studies.

Currently Enrolling

Disease Indication Study Information
Systemic Lupus Erythematosus

IM011-021: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus

Lupus Nephritis

IM011-073: A Phase 2 Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis

Giant Cell Arteritis

M16-852: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis

Rheumatoid Arthritis

STUDY00004744: Phase IV Open-Label Study to Evaluate Biomarkers to Predict the Efficacy of Abatacept in Subjects with Rheumatoid Arthritis

Systemic Lupus Erythematosus or Healthy Adults

HSD50655: Photoprovocation Testing in Subjects with Systemic Lupus Erythematosus

Open to All

STUDY00003007: Rheumatic Disease Biorepository & Patient Registry

 

Upcoming Study Areas

Stay tuned for more information on upcoming studies for Systemic Lupus Erythematosus, Rheumatoid Arthritis, Giant Cell Arteritis, Lupus Nephritis, Psoriatic Arthritis and Scleroderma.

Contact Us

Connect with the team via email or call to speak with our Research Manager.

Email: RheumResearch@medicine.washington.edu

Phone: 206-616-5330

If you have questions, are interested in participating, or want to sponsor a study at our site, let us know!